Consistent with this proposed role by which WDR5 may support tumor growth and survival, depletion of KMT2D in multiple pancreatic cancer cell lines increased their responsiveness to 5-FU [10] suggesting the possibility that KMT2/MLL inhibitors could be used for chemotherapy or radiation sensitization. The gene discussed is WDR5; the disease is pancreatic neoplasm.